Business
EIS and VCT Qualifying Status and Issue of Equity
EIS and VCT Qualifying Status and Issue of Equity.
About this update from Immupharma Plc
[{"type":"text","content":"\n \nRNS Number : 5354Q Immupharma PLC 01 March 2016 \n\n 1 MARCH 2016\nImmuPharma PLC\nConfirmation of EIS and VCT Qualifying Status and Issue of Equity\n£8.4 million total proceeds raised by ImmuPharma within the recent Placing and Subscription\n \nImmuPharma PLC (LSE:IMM) (\"ImmuPharma\" or the \"Company\"), the specialist drug discovery and development company, announces that it has received advance assurance from HM Revenue and Customs that it is a qualifying holding for the purposes of the Venture Capital Trust rules (\"VCT Advance Assurance\") and a qualifying company for the purposes of the Enterprise Investment Scheme (\"EIS Advance Assurance\", together the \"Assurances\").\nFollowing receipt of the Assurances, the Company is pleased to announce the issue and allotment of the 2,856,539 new ordinary shares of 10 pence each (the \"New Ordinary Shares\") in respect of the EIS Shares and VCT Shares within the Placing and Subscription as described in the announcements on 5 February 2016 and 24 February 2016. This brings the total proceeds raised by the Company in connection with the Placing and Subscription to £8.4 million.\nApplication will be made to the London Stock Exchange plc for the admission of the 2,856,539 New Ordinary Shares to trading on AIM (\"Admission\"). Admission is expected to take place at 8 a.m. on 4 March 2016 (or such la...